| Literature DB >> 32488412 |
Yuichiro Hamamoto1,2, Hiroshi Harada2, Masaharu Kohara1, Keiichiro Honma2, Shin-Ichi Nakatsuka3, Eiichi Morii4.
Abstract
Secretory carcinoma (SC) of the salivary gland is a relatively newly described disease, separate from acinic cell carcinoma (ACC), which frequently displays ETV6-NTRK3 gene fusion. However, the differences between SC and ACC remain unclear. Here, histological reevaluation of 12 formerly diagnosed ACC cases was performed, which yielded a new diagnosis of SC in four cases due to a lack of obvious acinar-like cells. Immunohistochemically, phosphorylated signal transducer and activator of transcription 5 (p-STAT5) was expressed in SC but not in ACC, whereas discovered on GIST-1 (DOG1) was expressed in ACC but not in SC. Molecular analysis was possible in three SC cases, of which two showed the ETV6-NTRK3 fusion transcript on reverse-transcription polymerase chain reaction, as well as breaks in the ETV6 gene on fluorescence in situ hybridization. However, the remaining SC cases did not show this fusion transcript. Recently, several reports have suggested that SC might not be adequately diagnosed if the focus is placed solely on the ETV6-NTRK3 fusion gene due to genetic diversity. In this regard, immunohistochemistry of p-STAT5 and DOG1 is expected to be a useful alternative diagnostic tool to discriminate SC from ACC.Entities:
Keywords: Acinic cell carcinoma; ETV6-NTRK3; Phosphorylated signal transducer and activator of transcription 5; Salivary gland; Secretory carcinoma
Mesh:
Substances:
Year: 2020 PMID: 32488412 DOI: 10.1007/s00795-020-00256-4
Source DB: PubMed Journal: Med Mol Morphol ISSN: 1860-1499 Impact factor: 2.070